Developing and Implementing a New Prison-Based Buprenorphine Treatment Program.
Research suggests that buprenorphine treatment may be a promising intervention for incarcerated individuals with heroin addiction histories. However, its implementation varies from corrections-based methadone because of unique challenges regarding dosing, administration, and regulation. Describing the first randomized clinical trial of prison-initiated buprenorphine treatment in the United States, this manuscript focuses on how these obstacles were overcome through collaboration among correctional, treatment, and research personnel. Building on the present authors' work in developing prison-based methadone treatment, and considering the lack of experience in implementing corrections-based buprenorphine programs in the United States, this manuscript may serve as a guide for interested corrections officials, treatment providers, and researchers.
Kinlock
Timothy W
TW
Friends Research Institute, Inc.
Gordon
Michael S
MS
Schwartz
Robert P
RP
Fitzgerald
Terrence T
TT
Mt Sinai J Med. 2001 Jan;68(1):14-20
11135501
J Urban Health. 2005 Sep;82(3):411-9
15917502
Am J Drug Alcohol Abuse. 2005;31(3):433-54
16161728
J Addict Med. 2007 Sep;1(3):126-32
21768947
N Engl J Med. 2007 Jan 11;356(2):157-65
17215533
JAMA. 2008 Nov 19;300(19):2303-5
19017918
Drug Alcohol Depend. 2000 Feb 1;58(1-2):143-52
10669065
J Subst Abuse Treat. 2009 Oct;37(3):277-85
19339140
N Engl J Med. 2000 Nov 2;343(18):1290-7
11058673
Drug Alcohol Depend. 2009 Jan 1;99(1-3):222-30
18930603
Am J Psychiatry. 1994 Jul;151(7):1025-30
8010359
Clin Pharmacol Ther. 2004 Jan;75(1):34-48
14749690
J Urban Health. 2004 Dec;81(4):645-54
15466845
Ann Med Interne (Paris). 2002 May;153(3 Suppl):1S14-9
12218878
Addiction. 2003 Apr;98(4):441-52
12653814
Addiction. 2008 Feb;103(2):251-5
18199304
J Urban Health. 2002 Dec;79(4):579-85
12468677
MMWR Morb Mortal Wkly Rep. 2006 Jun 2;55(21):589-92
16741494